TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹10,151 Cr | ₹-2,298 Cr | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹10,151 Cr |
| Mar2025 | ₹-2,298 Cr |
| Mar2024 | ₹-2,780 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹-1,781 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,151 Cr | Positive | |
| Mar2025 | ₹-2,298 Cr | Negative | |
| Mar2024 | ₹-2,780 Cr | Negative | |
| Mar2023 | ₹77 Cr | Positive | |
| Mar2022 | ₹-1,781 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹186,053.6 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
| MANKIND PHARMA | ₹94,793.9 Cr | 2.2% | -4% | -13.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.8% |
-1.7% |
34.7% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses